Table 2 Patient outcomes (N = 115).
Overall survival* | Â |
   Median (months) | 19 |
   1-yr (%) | 72 |
   2-yr (%) | 38 |
Distant metastasis-free survival* | Â |
   Median (months) | 35 |
   1-yr (%) | 90 |
   2-yr (%) | 60 |
Local control* | Â |
   Median (months) | not reached |
   1-yr (%) | 83 |
   2-yr (%) | 60 |
Disease-free survival* | Â |
   Median (months) | 14 |
   1-yr (%) | 63 |
   2-yr (%) | 28 |